Delivery Order SPE2DB22D3301-SPE2DB24FZ0TU
Award Date
7/16/24
Potential Completion Date
7/17/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.94 firm fixed-price delivery order is for the supply of Ropinirole HCL ER 8 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $1,570.56, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease. The award has a ceiling value of $7,780.64 and an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $4,917.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract is for the delivery of Ropinirole HCL ER 8 mg tablets, a medication used to treat Parkinson's disease. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract does not have a set-aside designation, indicating it was awarded...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract has a ceiling value of $1,668.36 and an ultimate completion date of December 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of Ropinirole HCL ER 6 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $6,555.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,593.30, is for the delivery of ropinirole HCL ER 8 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,596.22 firm-fixed-price delivery order is for the supply of ropinirole HCl ER 8 mg tablets, with a performance period through August 2024. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,314.25 firm fixed-price contract is for the delivery of ROPINIROLE HCL ER 8 MG tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,157.56, is a delivery order to supply 4567632555 ! ROPINIROLE HCL ER 12 MG TABLET 30S, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...